Ibrahim Ozgul

Ibrahim Ozgul

Auto-generated profile, based on publicly available information

Ibrahim Ozgul

Middle East Technical University (METU)

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2023 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
DDDidem Naz Dioken
Didem Naz Dioken
IOIbrahim Ozgul
Ibrahim Ozgul
IYIrem Yilmazbilek
Irem Yilmazbilek
MYMustafa Cengiz Yakicier
Mustafa Cengiz Yakicier
EKEzgi Karaca
Ezgi Karaca
AEAYSE ERSON-BENSAN
AYSE ERSON-BENSAN

21 September 2025 in RNA Biology
Verified
Journal Article
Open access
DDDidem Naz Dioken
Didem Naz Dioken
IOIbrahim Ozgul
Ibrahim Ozgul
IYIrem Yilmazbilek
Irem Yilmazbilek
EAElanur Almeric
Elanur Almeric
IEIrem Cemile Eroglu
Irem Cemile Eroglu
AEAYSE ERSON-BENSAN
AYSE ERSON-BENSAN
Oestrogen receptor alpha (ERα)-positive (ER+) breast cancers are driven by the binding of 17β-oestradiol (E2) to ERα, which transcriptionally regulates target genes. Although microarrays and conventional RNA sequencing have identified E2 target genes, pre-designed probes and short read lengths are limited in their ability to accurately capture complex transcript structures. Long-read sequencing offers a solution by spanning entire transcripts, providing a more complete view of the transcriptome. Here, we employed nanopore long-read direct RNA sequencing (DRS) complemented with 3'-end sequencing, in vitro experiments, and deep learning-based protein modelling to explore the landscape of the E2-responsive transcriptome and protein level implications. Our analysis revealed a range of E2-responsive non-coding and coding isoforms, including intronically polyadenylated (IPA) mRNAs. One of these IPA isoforms was detected for TLE1, which assists ERα-chromatin interactions for a subset of E2 targets. The IPA isoform produces a C-terminus truncated protein that lacks the WDR interaction domain but retains dimerization/tetramerization capacity through its intact N-terminal Q-domain. Structural modelling and protein-based assays confirmed the dimerization potential and nuclear localization of the truncated protein. Functional assays showed that the overexpression of truncated TLE1 reduced the E2-induced upregulation of TFF1 and GREB1, E2-responsive genes, thereby disrupting transcriptional regulation. Importantly, a lower IPA isoform ratio is associated with worse survival in ER+ breast cancers, highlighting clinical relevance. Our study revealed new layers of complexity in the E2-regulated transcriptome, providing insights into truncated proteins. These findings contribute to a deeper understanding of gene regulation and may help the development of new therapeutic strategies.

9 September 2023 in Heliyon
Verified
Journal Article
Open access
DDDidem Naz Dioken
Didem Naz Dioken
IOIbrahim Ozgul
Ibrahim Ozgul
GBGozde Koksal Bicakci
Gozde Koksal Bicakci
KGKemal Gol
Kemal Gol
TCTolga Can
Tolga Can
AEAYSE ERSON-BENSAN
AYSE ERSON-BENSAN
Early diagnosis and therapeutic targeting are continuing challenges for gynecological cancers. Here, we focus on cancer transcriptomes and describe the differential expression of 3′UTR isoforms in patients using an algorithm to detect differential poly(A) site usage. We find primarily 3′UTR shortening cases in cervical cancers compared with the normal cervix. We show differential expression of alternate 3′-end isoforms of FOXP1, VPS4B, and OGT in HPV16-positive patients who develop high-grade cervical lesions compared with the infected but non-progressing group. In contrast, in ovarian cancers, 3′UTR lengthening is more evident compared with normal ovary tissue. Nevertheless, highly malignant ovarian tumors have unique 3′UTR shortening events (e.g., CHRAC1, SLC16A1, and TOP2A), some of which correlate with upregulated protein levels in tumors. Overall, our study shows isoform level deregulation in gynecological cancers and highlights the complexity of the transcriptome. This transcript diversity could help identify novel cancer genes and provide new possibilities for diagnosis and therapy.

2 August 2025 in bioRxiv
Verified
Preprint
Open access
DDDidem Naz Dioken
Didem Naz Dioken
IOIbrahim Ozgul
Ibrahim Ozgul
IYIrem Yilmazbilek
Irem Yilmazbilek
EAElanur Almeric
Elanur Almeric
IEIrem Cemile Eroglu
Irem Cemile Eroglu
AEAYSE ERSON-BENSAN
AYSE ERSON-BENSAN
Estrogen receptor alpha (ERα)-positive (ER+) breast cancers are driven by 17β-estradiol (E2) binding to ERα, which transcriptionally regulates downstream target genes. Although microarrays and conventional RNA sequencing have identified E2 target genes, pre-designed probes and short read lengths are limited in accurately capturing complex transcript structures. Long-read RNA sequencing offers a solution by spanning entire transcripts, providing a more complete view of the transcriptome. Here, we employed nanopore long-read direct RNA sequencing (DRS) complemented with 3’-end sequencing, in vitro experiments, and deep learning-based protein modeling to explore the intricate landscape of E2-responsive transcriptome and protein level implications. Our analysis revealed a range of E2-responsive non-coding and coding isoforms, including intronically polyadenylated (IPA) mRNAs. One of these IPA isoforms was detected for TLE1 (Transducin-like enhancer protein 1), which positively assists ERα-chromatin interactions for a subset of E2 target genes. The IPA isoform produces a C-terminus truncated protein, lacking the WDR interaction domain, but retains dimerization/tetramerization capacity through its intact N-terminus Q-domain. Structural modeling and protein-based assays confirmed the truncated protein’s dimerization potential and nuclear localization. Functional assays showed that overexpression of truncated TLE1 reduces the E2-induced upregulation of GREB1 , an E2-responsive gene, thereby disrupting transcriptional regulation. Importantly, a lower IPA isoform ratio is associated with worse survival in ER+ patients, highlighting clinical relevance. Our study uncovers new layers of complexity in the E2-regulated transcriptome, providing insights into truncated proteins. These findings contribute to a deeper understanding of gene regulation and may help the development of new therapeutic strategies.